BioN­Tech ac­quires a for­mer No­var­tis man­u­fac­tur­ing fa­cil­i­ty in Sin­ga­pore

Pfiz­er’s mR­NA vac­cine part­ner BioN­Tech is spread­ing its man­u­fac­tur­ing reach across the globe, with its lat­est foothold in South­east Asia.

BioN­tech an­nounced on Mon­day that its Sin­ga­pore-based af­fil­i­ate, BioN­Tech Phar­ma­ceu­ti­cals Asia Pa­cif­ic Pte. Ltd., had en­tered in­to an agree­ment with No­var­tis to ac­quire a GMP man­u­fac­tur­ing fa­cil­i­ty in the coun­try, with the move de­signed to grow its foot­print in Asia.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER